nach oben

Zeitschrift für Herz-,Thorax- und Gefäßchirurgie

Erschienen in:

14.02.2019 | Herzinsuffizienz | CME

Lungenbeteiligung bei Herzkrankheiten

verfasst von: Prof. Dr. med. F. J. Meyer, S. Andreas, M. Held, H. Leuchte, H. Worth

Erschienen in: Zeitschrift für Herz-,Thorax- und Gefäßchirurgie | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Lungenbeteiligung bei Herzkrankheiten ist nicht immer eine direkte Schädigung, sondern oftmals eine Folge komplexer kardiorespiratorischer Interaktionen. Anhand 5 ausgewählter Situationen – Lungenfunktion und Ventilation im Schlaf bei chronischer Linksherzinsuffizienz, alveoläre Hämorrhagie unter Antikoagulation, infektiöse Rechtsherzendokarditis, Auswirkungen herzchirurgischer Eingriffe auf pulmonale Funktionen sowie Belastungsreaktion und Atemmuskelfunktion bei idiopathischer pulmonal arterieller Hypertonie – werden die diagnostischen und therapeutischen Herausforderungen dargestellt.

Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A (2016) Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med 194(11):1319–1336PubMedCrossRef

Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572–580PubMedPubMedCentralCrossRef

Chen YGH, Xu D, Xu X, Wang H, Hu X, Lu Z, Kwak D, Xu Y, Gunther R, Huo Y, Weir EK (2012) Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension 59:9

Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J 34(36):2795–2803PubMedCrossRef

Andreas S, Morguet AJ, Werner GS, Kreuzer H (1996) Ventilatory response to exercise and to carbon dioxide in patients with heart failure. Eur Heart J 17(5):750–755PubMedCrossRef

Chua TP, Coats AJ (1995) The lungs in chronic heart failure. Eur Heart J 16(7):882–887PubMedCrossRef

Clark AL, Poole-Wilson PA, Coats AJ (1996) Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28(5):1092–1102PubMedCrossRef

Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P et al (2008) The ventilatory classification system effectively predicts hospitalization in patients with heart failure. J Cardiopulm Rehabil Prev 28(3):195–198PubMedCrossRef

Apostolo ALP, Palange P, Agalbato C, Molle R, Popovic D (2015) Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 189:7CrossRef

10.

Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kubler W et al (2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103(17):2153–2158PubMedCrossRef

11.

Filusch A, Ewert R, Altesellmeier M, Zugck C, Hetzer R, Borst MM et al (2011) Respiratory muscle dysfunction in congestive heart failure—the role of pulmonary hypertension. Int J Cardiol 150(2):182–185PubMedCrossRef

12.

Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, Borst MM et al (2007) Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 101(11):2366–2369PubMedCrossRef

13.

Haarmann H, Folle J, Nguyen XP, Herrmann P, Heusser K, Hasenfuss G et al (2016) Sympathetic activation is associated with exercise limitation in COPD. COPD 13(5):589–594PubMedCrossRef

14.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37(27):2129–2200 (Developed with the special contribution of the Heart Failure Association (HFA) of the ESC)PubMedCrossRef

15.

Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC et al (2018) Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 6(5):368–378PubMedCrossRef

16.

Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d’Ortho MP, Erdmann E et al (2016) Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 4(11):873–881PubMedCrossRef

17.

Kip MS, Schönfelder T, Bleß H‑H (2015) Weißbuch Schlaganfallprävention bei Vorhofflimmern. Thieme, Stuttgart

18.

Nitta K, Imamura H, Akihiro Yashio A et al (2016) Diffuse alveolar hemorrhage associated with Edoxaban Therapy. Case Rep Crit Care. https://doi.org/10.1155/2016/7938062 PubMedPubMedCentralCrossRef

19.

Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS et al (2013) Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Am J Kidney Dis 62(3):591–594PubMedCrossRef

20.

Wijnen PA, Linssen CF, Haenen GR, Bekers O, Drent M (2010) Variant VKORC1 and CYP2C9 alleles in patients with diffuse alveolar hemorrhage caused by oral anticoagulants. Mol Diagn Ther 14(1):23–30PubMedCrossRef

21.

Greening AP, Hughes JM (1981) Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci 60(5):507–512PubMedCrossRef

22.

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Tleyjeh IM, Rybak MJ et al (2015) Infective Endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486PubMedCrossRef

23.

Habib G, Lancellotti P, Iung B (2016) 2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease. Heart 102(13):992–994PubMedCrossRef

24.

Frantz S, Buerke M, Horstkotte D et al (2016) Kommentar zu den 2015 Leitlinien der Europäischen Gesellschaft für Kardiologie zur Infektiösen Endokarditis. Kardiologe 10:7. https://doi.org/10.1007/s12181-016-0058-4 CrossRef

25.

Szelkowski LA, Puri NK, Singh R, Massimiano PS (2015) Current trends in preoperative, intraoperative, and postoperative care of the adult cardiac surgery patient. Curr Probl Surg 52(1):531–569PubMedCrossRef

26.

Urell C, Westerdahl E, Hedenstrom H, Janson C, Emtner M (2012) Lung function before and two days after open-heart surgery. Crit Care Res Pract 2012:291628PubMedPubMedCentral

27.

Westerdahl E, Lindmark B, Bryngelsson I, Tenling A (2003) Pulmonary function 4 months after coronary artery bypass graft surgery. Respir Med 97(4):317–322PubMedCrossRef

28.

Urell C, Emtner M, Hedenstrom H, Westerdahl E (2016) Respiratory muscle strength is not decreased in patients undergoing cardiac surgery. J Cardiothorac Surg 11:41PubMedPubMedCentralCrossRef

29.

Taggart DP (2000) Respiratory dysfunction after cardiac surgery: effects of avoiding cardiopulmonary bypass and the use of bilateral internal mammary arteries. Eur J Cardiothorac Surg 18(1):31–37PubMedCrossRef

30.

Altarabsheh SE, Deo SV, Dunlay SM, Erwin PJ, Obeidat YM, Navale S et al (2017) Meta-analysis of usefulness of concomitant mitral valve repair or replacement for moderate ischemic mitral regurgitation with coronary artery bypass grafting. Am J Cardiol 119(5):734–741PubMedCrossRef

31.

Weissman C (2004) Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth 8(3):185–211PubMedCrossRef

32.

Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC et al (2014) Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score. Crit Care Med 42(5):1150–1156PubMedCrossRef

33.

He S, Chen B, Li W, Yan J, Chen L, Wang X et al (2014) Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review. J Thorac Cardiovasc Surg 148(6):3148–3155 (e1–5)PubMedCrossRef

34.

Stephens RS, Shah AS, Whitman GJ (2013) Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 95(3):1122–1129PubMedCrossRef

35.

Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL (2006) Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 296(15):1851–1857PubMedCrossRef

36.

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 46(4):903–975 (The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT))PubMedCrossRef

37.

Meyer FJ, Ewert R, Hoeper MM, Olschewski H, Behr J, Winkler J et al (2002) Peripheral airway obstruction in primary pulmonary hypertension. Thorax 57(6):473–476PubMedPubMedCentralCrossRef

38.

Laveneziana P, Humbert M, Godinas L, Joureau B, Malrin R, Straus C et al (2015) Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 45(5):1495–1498PubMedCrossRef

39.

Naeije R (2014) Lung mechanics and exertional dyspnea in pulmonary arterial hypertension. Respiration 88(1):16–17PubMedCrossRef

40.

Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L et al (2013) Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 41(3):578–587PubMedCrossRef

41.

Droste AS, Rohde D, Voelkers M, Filusch A, Bruckner T, Borst MM et al (2009) Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension. Respir Res 10:129PubMedPubMedCentralCrossRef

42.

Meyer FJ, Lossnitzer D, Kristen AV, Schoene AM, Kubler W, Katus HA et al (2005) Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25(1):125–130PubMedCrossRef

43.

Kabitz HJ, Schwoerer A, Bremer HC, Sonntag F, Walterspacher S, Walker D et al (2008) Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci 114(2):165–171PubMedCrossRef

44.

Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429–435PubMedCrossRef

45.

Dumitrescu D, Sitbon O, Weatherald J, Howard LS (2017) Exertional dyspnoea in pulmonary arterial hypertension. Eur Respir Rev. https://doi.org/10.1183/16000617.0039-2017 PubMedCrossRef

46.

Richter MJ, Tiede H, Morty RE, Voswinckel R, Seeger W, Schulz R et al (2014) The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration 88(1):24–30PubMedCrossRef

47.

Richter MJ, Voswinckel R, Tiede H, Schulz R, Tanislav C, Feustel A et al (2012) Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. Respir Med 106(2):308–313PubMedCrossRef

48.

Meyer FJ, Borst MM, Buschmann HC, Ewert R, Friedmann-Bette B, Ochmann U et al (2013) Exercise testing in respiratory medicine. Pneumologie 67(1):16–34PubMedCrossRef

49.

Yan S, Kaminski D, Sliwinski P (1997) Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156(1):55–59PubMedCrossRef

50.

Criee CP, Baur X, Berdel D, Bosch D, Gappa M, Haidl P et al (2015) Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine. Pneumologie 69(3):147–164PubMedCrossRef

51.

Naeije R (2005) Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 25(1):6–8PubMedCrossRef

Titel: Lungenbeteiligung bei Herzkrankheiten
verfasst von: Prof. Dr. med. F. J. Meyer
S. Andreas
M. Held
H. Leuchte
H. Worth
Publikationsdatum: 14.02.2019
Verlag: Springer Medizin
Schlagwörter: Herzinsuffizienz
Endokarditis
Herzchirurgie
Herzchirurgie
Pulmonale Hypertonie
Pulmonale Hypertonie
Pulmonale Hypertonie
Pulmonale Hypertonie
Erschienen in: Zeitschrift für Herz-,Thorax- und Gefäßchirurgie / Ausgabe 2/2019
Print ISSN: 0930-9225
Elektronische ISSN: 1435-1277
DOI: https://doi.org/10.1007/s00398-019-0296-4

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Und zum Schluss einige W-Fragen …

Was tun bei degenerierten Aortenklappenprothesen?

Maude E. Abbott

„Valve-in-valve-in-valve-in-valve“ …?

S3-Leitlinie: Beatmung und ECMO bei akuter respiratorischer Insuffizienz

Aorta-ascendens-Ersatz bei bikuspider Aortenklappe